Nike Shifts China Online Sales Strategy to Boost Brand and Fight Local Rivals 
Intel, AMD Seek Long-Term China Server CPU Deals as AI Demand Drives Supply Crunch 
Tabletop particle accelerator could transform medicine and materials science 
South Korea Q2 GDP Beats Forecasts as AI Chip Exports Drive Growth 
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates 
Elon Musk Fuels SpaceX-Tesla Merger Speculation After Earnings Call 
Blue Origin’s New Glenn Achieves Breakthrough Success With First NASA Mission 
NIH Infectious Disease Leadership Shake-Up Raises Concerns Amid Ebola, Hantavirus Outbreaks 
Trump Signs Executive Order to Boost AI Research in Childhood Cancer 
Ryanair Warns Summer Airfares May Stay Lower as Quarterly Profit Misses Estimates 
Super Micro Computer Stock Jumps 20% After Record AI Orders and Margin Surge 
US Dollar Pauses Rally as Middle East Tensions Support Safe-Haven Demand 
Japan PM Sanae Takaichi Unveils Growth Plan as BOJ Independence Concerns Lift Bond Yields 
GE Vernova Q2 Revenue Tops Estimates as Earnings Miss, Shares Slide Despite Higher 2026 Outlook 
Lockheed Martin Unveils Lower-Cost Patriot ACE Interceptor to Meet Rising Air Defense Demand 
Eli Lilly Eyes AtaiBeckley Acquisition to Expand Psychedelic Mental Health Pipeline 
A South Korean research team has developed a strip-type urine test that successfully diagnoses prostate and pancreatic cancer on-site by amplifying the optical signal of the metabolome in urine.
The joint research team is from the Korea Institute of Materials Science, Pohang University of Science and Technology, and Kyung Hee University
The surface-enhanced Raman scattering sensor that they developed can amplify the optical signal of the metabolome in urine by more than 1 billion times by forming a coral reef-shaped plasmonic nanomaterial on top of porous paper material.
A light irradiation after a 10-microliter urine droplet amplified signal of cancer metabolome on the sensor’s surface without the need to go through a separate analysis process,.
The application of an artificial intelligence-based analytical method for the spectrum signal generated through the irradiation of light into the urine can identify people with prostate cancer and pancreatic cancer with an accuracy of up to 99 percent.
